process
method
use
bank
skin
subsequ
therapeut
use
depend
whether
skin
retain
viabil
viabl
skin
graft
sterilis
techniqu
appli
howev
antibiot
antimycot
may
use
disinfect
tissu
respect
bacteria
fungi
nevertheless
strict
standard
appli
avoid
diseas
transmiss
donor
recipi
involv
donor
medic
histori
donor
test
viral
diseas
asept
retriev
process
control
storag
temperatur
cryopreserv
prefer
method
long
term
storag
viabl
skin
graft
viabil
requir
addit
long
term
preserv
method
may
use
includ
deepfreez
freezedri
high
concentr
solut
preserv
three
method
work
reduc
water
activ
addit
possibl
appli
certain
sterilis
techiqu
shown
damag
tissu
import
sterilis
method
valid
accord
precis
definit
sterilis
initi
level
bbioburdenq
expect
present
immedi
prior
applic
sterilis
method
applic
improv
refin
methodolog
accord
defin
standard
ensur
improv
graft
perform
reduc
risk
recipi
elsevi
inc
right
reserv
one
major
concern
use
skin
allograft
risk
diseas
transmiss
case
involv
see
front
matter
allogen
skin
may
bank
viabl
nonviabl
graft
choic
critic
affect
way
skin
process
preserv
viabl
skin
allograft
may
obtain
live
donor
frequent
cadaver
donor
latter
case
immedi
circulatori
arrest
skin
becom
ischem
lead
progress
cell
death
period
day
acceler
higher
temperatur
even
cadav
immedi
place
refriger
bodi
cool
slow
rate
lead
least
warm
ischemia
time
nevertheless
viabl
skin
still
retriev
circa
hour
death
bodi
quickli
refriger
howev
skin
subject
much
longer
warm
ischemia
period
result
acceler
deterior
viabil
skin
remov
bodi
howev
cool
rapidli
immers
refriger
solut
thu
immedi
reduc
rate
cell
death
transmiss
hiv
skin
donor
recipi
report
apart
viral
diseas
also
possibl
transfer
pathogen
bacteria
fungi
parasit
within
skin
allograft
reason
consensu
around
world
method
use
minim
risk
diseas
transmiss
detail
standard
guidelin
issu
nation
organizationsassoci
nation
blood
servic
british
associ
tissu
bank
multin
organ
exampl
european
associ
tissu
bank
import
local
standard
consult
certain
diseas
may
confin
novel
diseas
aris
certain
part
world
recent
spread
west
nile
viru
unit
state
sever
acut
respiratori
syndrom
china
case
point
brief
summari
gener
approach
given
medic
record
held
hospit
famili
doctor
other
must
screen
condit
would
exclud
donat
may
includ
current
system
infect
diseas
unknown
etiolog
previou
infect
possibl
current
carrier
statu
hepat
malaria
etc
may
also
prudent
exclud
histori
malign
diseas
particularli
skin
might
use
immunosuppress
patient
exampl
suffer
massiv
burn
injuri
behavior
histori
may
also
ground
reject
donor
owe
high
correl
activ
intraven
drug
abus
viral
infect
hiv
hepat
tissu
bank
standard
gener
set
limit
maximum
warm
cold
ischemia
time
permit
death
donor
known
bacteria
gut
releas
vascular
system
postmortem
migrat
intern
organ
tissu
reduc
popul
bacteria
resid
skin
skin
tissu
possess
mix
commens
popul
bacteria
fungi
live
primarili
around
hair
sebac
follicl
except
staphylococcu
aureu
rel
nonpathogen
addit
transient
popul
contamin
bacteria
howev
may
also
natur
present
may
result
contamin
skin
retriev
process
even
commens
bacteria
may
damag
skin
subsequ
allow
grow
skin
storag
period
reach
massiv
popul
densiti
therefor
import
tri
elimin
minim
microbi
popul
skin
retriev
gener
achiev
use
skin
prep
techniqu
similar
use
skin
patient
undergo
oper
hospit
bank
skin
viabl
state
import
valid
prep
agent
adequ
remov
harvest
skin
residu
toxic
skin
cell
although
effect
reduc
bioburden
skin
prep
unlik
total
elimin
bacteria
therefor
essenti
prevent
prolifer
residu
bacteria
retriev
transport
subsequ
process
maintain
skin
refriger
wet
ice
temperatur
prevent
prolifer
bacteria
elimin
residu
bacteria
fungi
viabl
skin
antibioticantimycot
cocktail
may
use
use
reduc
temperatur
skin
may
incub
hour
cocktail
howev
antibiot
effect
temperatur
includ
normotherm
temperatur
antibiot
consid
howev
exposur
period
minim
even
skin
place
oxygen
nutrientrich
medium
ischem
necrosi
tissu
still
occur
diffus
path
tissu
peripheri
central
cell
extens
therefor
oxygen
nutrient
diffus
fast
enough
suppli
cell
toxic
metabolit
remov
quickli
enough
result
central
necrosi
radiat
eventu
includ
tissu
reduc
temperatur
reduc
metabol
rate
cell
henc
nutrit
demand
metabolit
product
therefor
one
method
explor
viabl
storag
skin
use
refriger
temperatur
without
nutrient
media
earli
wentscher
report
success
storag
graft
skin
autograft
temperatur
near
day
studi
carrel
use
normotherm
hypotherm
storag
condit
confirm
util
latter
eventu
refriger
storag
skin
autograft
becam
norm
burn
unit
simplest
techniqu
fold
skin
cut
surfac
apposit
wrap
skin
sandwich
tull
gra
andor
salin
gauz
prevent
desicc
use
method
autolog
skin
use
around
week
storag
although
cell
viabil
low
point
unlik
autograft
allograft
alreadi
lost
viabil
time
retriev
therefor
maximum
storag
time
use
method
reduc
day
extens
microbiolog
screen
howev
requir
togeth
scrutini
medic
record
postmortem
report
short
storag
period
insuffici
mani
attempt
made
extend
refriger
storag
period
skin
addit
homolog
serum
found
benefici
provid
nutrient
dilut
buffer
acid
produc
byproduct
metabol
altern
tissu
cultur
media
sourc
nutrient
variou
buffer
system
evalu
howev
extend
slightli
period
use
storag
therefor
although
refriger
storag
skin
prove
use
method
temporari
storag
viabl
autograft
current
suitabl
allograft
better
method
longterm
preserv
skin
graft
cryopreserv
techniqu
facilit
cool
tissu
ultralow
temperatur
protect
viabil
cell
cell
type
optimum
cool
rate
produc
maxim
cell
surviv
either
side
optimum
surviv
fall
away
fig
cool
rate
faster
optimum
intracellular
ice
appear
caus
cell
die
contrast
cool
slower
optimum
cell
spend
longer
time
expos
high
salt
concentr
build
water
remov
solut
form
extracellular
ice
crystal
cell
also
shrink
osmosi
differ
type
cell
within
tissu
unlik
cell
type
exhibit
optimum
cool
rate
therefor
maintain
high
viabil
cell
would
imposs
achiev
howev
cryoprotect
chemic
ad
cell
freez
sever
cryoprotect
chemic
identifi
sinc
chanc
discoveri
polg
et
al
glycerol
abl
protect
sperm
cell
cryogen
damag
gener
properti
cryoprotect
molecul
pass
cell
membran
cell
rel
nontox
high
multimolar
concentr
commonest
cryoprotect
agent
cpa
glycerol
dimethyl
sulfoxid
cryoprotect
agent
abl
prevent
solut
effect
injuri
mode
action
probabl
first
act
solvent
salt
thu
reduc
salt
concentr
cell
subject
high
subzero
temperatur
solut
effect
damag
addit
presenc
within
cell
prevent
excess
shrinkag
cell
cool
phase
therefor
presenc
cpa
possibl
use
slow
cool
rate
minim
intracellular
ice
format
protect
cell
solut
effect
high
viabil
cell
type
thu
achiev
use
slow
cool
rate
mani
tissu
optimum
cool
rate
around
per
minut
cpa
use
although
cpa
rel
nontox
low
temperatur
toxic
becom
signific
higher
temperatur
addit
rate
cpa
enter
cell
temperatur
cpa
depend
faster
higher
temperatur
therefor
optimum
temperatur
exposur
time
need
valid
basal
medium
cpa
dissolv
incub
skin
tissu
balanc
salt
solut
mani
commerci
tissu
cultur
media
prove
satisfactori
mani
buffer
system
use
media
normotherm
temperatur
howev
lose
buffer
capac
lower
temperatur
cryopreserv
purpos
zwitterion
buffer
hepe
te
shown
work
well
cool
rate
per
minut
achiev
accur
use
controlledr
cool
apparatu
approxim
achiev
howev
place
tissu
insul
contain
within
deep
freez
vapor
phase
liquid
nitrogen
mani
differ
protocol
advoc
packag
longterm
storag
skin
rang
roll
skin
within
tube
use
flat
pack
metal
lamin
pouch
latter
gener
prefer
greater
surfac
area
volum
ratio
ensur
even
cool
across
skin
tissu
metal
lamin
good
conductor
heat
tissu
normal
pack
flat
pack
bag
inner
outer
bag
steril
facilit
asept
handl
thaw
clinic
applic
skin
tissu
presenc
cpa
cool
rate
per
minut
ensur
surviv
cell
within
tissu
cool
rate
increas
howev
cell
popul
sequenti
advers
affect
mani
cell
bodi
deriv
leukocyt
close
relat
lineag
known
exquisit
sensit
cryogen
injuri
deplet
immunostimulatori
bpasseng
leukocytesq
demonstr
increas
cool
rate
pancreat
islet
langerhan
maintain
viabil
insulinproduc
islet
cell
concept
cool
ratedepend
immunomodul
evalu
skin
tissu
cool
rate
per
minut
shown
maintain
viabil
keratinocyt
fibroblast
reduc
immunogen
assess
mix
epiderm
celllymphocyt
respons
assay
murin
allograft
assum
due
effect
faster
cool
rate
major
immunostimulatori
cell
skinth
langerhan
cell
skin
tissu
cool
controlledr
process
least
transfer
longterm
storag
vapor
phase
liquid
nitrogen
vapor
phase
current
prefer
owe
case
viru
transmiss
pack
bone
marrow
store
liquid
phase
presum
gross
contamin
give
set
port
marrow
bag
virus
present
liquid
nitrogen
nitrogen
becom
contamin
ruptur
bag
contain
marrow
patient
subsequ
shown
posit
hepat
b
skin
temperatur
lower
loss
cell
viabil
incur
skin
requir
graft
purpos
transport
user
hospit
either
liquid
nitrogen
dri
shipper
temperatur
togeth
dri
ice
co
insul
contain
optimum
thaw
procedur
rapid
warm
method
achiev
plung
pack
skin
water
bath
tissu
thaw
prolong
storag
presenc
cpa
would
detriment
outer
bag
disinfect
cut
along
margin
inner
bag
remov
asept
steril
field
asept
open
inner
bag
skin
remov
steril
kidney
dish
rins
remov
cpa
solut
cell
contain
high
concentr
cpa
hyperosmot
compar
normal
salin
avoid
osmot
lysi
cell
either
salin
ad
gradual
imperm
solut
sucros
ad
salin
reduc
differ
osmolar
soon
wash
procedur
complet
skin
appli
immedi
wound
viabil
declin
rapidli
thaw
skin
storag
use
recommend
skin
cell
viabil
retain
nonviabl
allograft
open
mani
possibl
preserv
steril
skin
tissu
principl
method
longterm
preserv
avoid
degrad
chang
may
occur
presenc
water
includ
microbi
growth
would
pose
infect
risk
also
would
result
damag
matrix
enzymat
degrad
enzym
releas
skin
cell
bacteria
could
caus
signific
damag
oxid
reaction
may
occur
exampl
lipid
peroxid
chain
reaction
result
rancid
fat
toxic
bone
hydrolyt
reaction
also
damag
matrix
compon
detrimen
tal
reaction
depend
water
present
fig
therefor
remov
immobil
sequestr
water
basi
longterm
preserv
tissu
graft
achiev
main
way
deep
freez
freez
point
tissu
ice
nucleat
occur
temperatur
fall
ice
crystal
form
exist
crystal
grow
ice
crystal
pure
water
henc
remain
solut
becom
progress
concentr
eventu
point
reach
littl
free
water
left
solut
facilit
microbi
growth
degrad
chemic
reaction
temperatur
longterm
preserv
achiev
practic
storag
deep
freez
prove
satisfactori
longterm
storag
freez
dri
process
involv
remov
water
skin
frozen
state
sublim
achiev
appli
vacuum
tissu
condens
remov
water
molecul
downstream
sublim
frozen
state
help
protect
molecul
would
otherwis
advers
affect
high
salt
concentr
higher
temperatur
exampl
denatur
protein
dri
must
continu
enough
water
remov
prevent
degrad
reaction
equat
less
residu
water
measur
gravimetr
although
accept
tissu
bank
standard
bresidu
waterq
ident
bwater
activ
q
appropri
measur
us
navi
tissu
bank
first
commenc
largescal
freez
dri
human
tissu
implant
earli
use
freezedri
skin
first
report
subsequ
shown
freez
dri
reduc
immunogen
skin
without
interf
benefici
properti
use
highconcentr
solut
high
concentr
salt
sugar
use
centuri
longterm
preserv
food
item
principl
solut
molecul
abl
sequest
water
molecul
hydrat
shell
around
molecul
water
within
hydrat
shell
almost
crystallin
natur
unabl
particip
chemic
reaction
euroskin
bank
develop
solut
preserv
method
use
glycerol
skin
incub
success
concentr
glycerol
solut
maintain
long
term
glycerol
recent
glycerol
water
flux
kinet
character
effici
valid
protocol
propos
water
activ
skin
differ
glycerol
concentr
measur
use
commerci
avail
instrument
studi
demonstr
concentr
origin
chosen
euroskin
bank
optim
minim
degrad
reaction
glycerol
techniqu
use
preserv
skin
import
glycerol
remov
skin
clinic
use
achiev
repeatedli
wash
skin
physiolog
salin
process
must
valid
skin
bank
least
minut
requir
remov
glycerol
failur
remov
glycerol
may
lead
high
system
concentr
use
open
wound
high
dose
glycerol
toxic
effect
muscl
lead
myonecrosi
muscl
breakdown
product
may
result
renal
failur
even
death
ld
glycerol
mlg
viabl
skin
allograft
possibl
appli
steril
techniqu
steril
method
tend
inactiv
human
cell
equal
greater
rate
bacteri
cell
best
achiev
combin
serolog
screen
virus
bacteri
disinfect
use
antibiot
cocktail
nonviabl
graft
rang
steril
techniqu
consid
dri
heat
autoclav
damag
structur
skin
tissu
includ
denatur
collagen
henc
suitabl
techniqu
success
use
includ
ethylen
oxid
ga
c
irradi
concern
limit
method
howev
begin
appear
ethylen
oxid
ga
reaction
product
chlorideethylen
chlorohydrinar
toxic
although
accept
level
compound
propos
recent
data
suggest
safe
level
ethylen
oxid
respect
genotox
therefor
move
away
use
steril
question
also
rais
effect
c
irradi
mani
small
virus
sporeform
bacteria
fairli
resist
c
irradi
high
dose
would
requir
inactiv
hiv
windowperiod
donor
kgi
would
caus
extens
damag
tissu
matrix
includ
collagen
denatur
therefor
current
consider
whether
bsterilizationq
achiev
instead
use
combin
microbi
inactiv
procedur
understand
might
achiev
requir
understand
concept
steril
given
microbi
inactiv
procedur
appli
particular
situat
rate
microbi
inactiv
usual
approxim
shown
fig
increas
amount
inactiv
requir
fewer
fewer
surviv
microorgan
although
line
becom
vanishingli
close
xaxi
never
cross
thu
asymptot
therefor
never
possibl
guarante
absenc
microorgan
steril
statist
phenomenon
log
scale
use
microbi
popul
densiti
inactiv
curv
approxim
straight
line
straight
line
valu
calcul
steril
dose
requir
reduc
microbi
densiti
log
fig
line
cross
xaxi
indic
averag
less
viabl
organ
per
item
steril
statist
phenomenon
reach
indic
viabl
microb
everi
item
treat
food
drug
administr
recent
indic
claim
steril
bank
tissu
product
enough
steril
dose
appli
reach
level
viabl
microb
per
million
tissu
item
steril
possibl
destruct
cultur
million
tissu
graft
valu
obtain
extrapol
line
fig
level
use
valu
concept
refer
steril
assur
level
sal
reach
sal
level
xaxi
clearli
requir
valu
addit
valu
howev
requir
move
origin
bioburden
xaxi
initi
bioburden
low
exampl
microb
per
graft
log
addit
valu
requir
give
total
reach
sal
hand
million
microb
per
graft
log
addit
valu
requir
give
total
studi
ethylen
oxid
steril
bone
graft
valu
shown
minut
exposur
ga
therefor
case
valu
equat
minut
exposur
wherea
valu
requir
minut
exposur
c
irradi
valu
clostridium
speci
around
kgi
take
bioburden
rang
bacteria
per
graft
requir
total
valu
respect
reach
sal
respect
irradi
dose
requir
would
kgi
irradi
dose
circa
kgi
caus
collagen
denatur
therefor
latter
case
rather
reli
irradi
achiev
requir
reduct
would
prefer
use
altern
method
reduc
initi
bioburden
exampl
circa
irradi
final
reduct
step
author
recent
evalu
use
peracet
acid
steril
skin
graft
major
advantag
chemic
agent
breakdown
productsacet
water
oxygenar
nontox
peracet
acidtr
skin
shown
exhibit
biocompat
properti
vitro
compat
highconcentr
glycerol
preserv
techniqu
whether
peracet
acid
alon
achiev
sal
current
investig
applic
steril
step
significantli
reduc
risk
crossinfect
therefor
support
use
nonviabl
skin
nonlifethreaten
wound
ulcer
evid
repeat
applic
skin
graft
ulcer
reduc
bacteri
load
help
condit
wound
bed
stimul
heal
prepar
wound
autograft
conclus
skin
allograft
continu
import
therapeut
tool
develop
surgic
skin
bank
individu
burn
unit
larg
given
way
larg
region
nation
skin
multitissu
bank
facilit
rigor
tissu
process
scientif
valid
process
procedur
use
increas
regul
accredit
skin
bank
government
intergovernment
agenc
strengthen
skin
process
bank
standard
thu
ensur
high
level
safeti
efficaci
